Detail of the clinical trial
| Title of the trial | A double-blind, randomized, stratified, multi-center trial evaluating conventional and high dose oseltamivir in the treatment of immunocompromised patients with influenza |
|---|---|
| EudraCT number | 2006-002468-24 |
| Protocol number | NV20234 (3.podání) |
| Sponsor | F.Hoffmann-La Roche Ltd. |
| Indications | Vaccination |
| Diagnosis | influenza in immunocompromised patients |
| Population in clinical trial |
Infants and Toddlers (28 days - 23 months) Children (2-11 years) Adolescents (12-17 years) Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2011 |
| Date of approval by Institute (SÚKL) | 2.3.2011 |
| Date of approval by EC | 7.11.2007 |
| Date of initiation CT in ČR | 6.1.2012 |
| Date of ending CT in ČR | 8.4.2015 |
| Notice | |
| Sites |
Klinika dětské hematologie a onkologie UK 2. LF, Motol Praha RA, B. Němcové 113, Terezín, 411 55 Kasmed s.r.o., Klokotská 10, Tábor, 390 01 RA, Štefánikova 477, Zlín, 760 01 |
cz